Skip to main content
OpenTrials
Completed

NCT Number: NCT00642681

Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge

Effect of upper respiratory infection (URI) on diabetic subjects with a meal challenge

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Parkwood Hospital, London, Ontario, Canada

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects will have met the same inclusion criteria as MKC-TI-030
  • Clinical diagnosis of URI with in 24 hrs prior to clinic visit and/or day of clinic visit
  • At least 3 URI symptoms

Exclusion criteria

  • Prior participation in MKC-TI-112
  • MedHist, PE or lab findings of acute bacterial infection including but not limited to sputum prod., nasal/eye discharge, chest exam abnormalities, CXR findings of pneumonia.

Treatment and study plan

Technosphere Insulin

Drug

Technosphere® Insulin (TI) Inhalation Powder, prandial

Primary outcomes

  1. To measure Serum FDKP AUC

    Time frame: 4 Hours

Sponsors and collaborators

Lead sponsor

Mannkind Corporation

Industry

Registry information

Official study title

Evaluation of the Effect of Symptomatic Upper Respiratory Infections on Pharmacological Characteristics of Technosphere®/Insulin in Subjects With Diabetes Mellitus After a Meal Challenge

Important dates

Study start
2007
Primary completion
2008
Study completion
2008
First posted
Mar 25, 2008
Registry last updated
Dec 3, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.